Home » Stocks » FWP

Forward Pharma A/S (FWP)

Stock Price: $9.65 USD -0.34 (-3.40%)
Updated Jul 30, 2021 4:00 PM EDT - Market closed
After-hours: $9.39 -0.26 (-2.69%) Jul 30, 7:44 PM
Market Cap 67.73M
Revenue (ttm) n/a
Net Income (ttm) -6.45M
Shares Out 7.02M
EPS (ttm) -0.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 30
Last Price $9.65
Previous Close $9.99
Change ($) -0.34
Change (%) -3.40%
Day's Open 9.42
Day's Range 9.29 - 10.50
Day's Volume 462,759
52-Week Range 5.80 - 20.31


Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated f...

3 months ago - GlobeNewsWire

COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures against the spread o...

6 months ago - GlobeNewsWire

There are investors who purchase shares of stocks that are trading below their liquidation value in the belief that they can make huge gains out of their investments after the market has reassessed the ...

Other stocks mentioned: APWC, SPRT
1 year ago - GuruFocus

Forward Pharma: Heads You Win Big, Tails You Still Win

1 year ago - Seeking Alpha

COPENHAGEN, Denmark, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced that its Board of Directors has approved a change in the number of i...

1 year ago - GlobeNewsWire

COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fal...

1 year ago - GlobeNewsWire

About FWP

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Claus Svendsen
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

Financial Statements